Tuesday, March 04, 2025 | 10:12 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

BPL Medical Technolgies appoints Sunil Khurana as CEO

Goldman Sachs Group Inc had invested Rs 110 crore ($20 million) in BPL Medical Technologies for acquiring minority stake

<a href="http://www.shutterstock.com/pic-136518497/stock-photo-girl-student-holding-a-microtube.html" target="_blank">Clinical Trial</a> image via Shutterstock

Reghu Balakrishnan Mumbai
BPL Medical Technologies, the medical device company, has appointed Sunil Khurana as President & CEO. He will also become a director on the Board of BPL Med. 

Sunil joins BPL from Bharti Infratel, provider of tower telecom infrastructure, where he was the Chief Operating Officer and a member of the Core Executive Council. Prior to Bharti Infratel, Sunil spent close to three decades with the GE Group in it medical devices business.
 
In May this year, Goldman Sachs Group Inc had invested Rs 110 crore ($20 million) in BPL Medical Technologies for acquiring minority stake.

Sunil Khurana said, “I am delighted to join the BPL Group, one of India's pioneers in the medical technologies space, and excited to leverage BPL’s strong brand, well-established manufacturing capabilities and distribution network to create India’s leading, medical device company.”
 
 
Established in 1963, British Physical Laboratory (BPL) Limited started manufacturing precision electrical instrumentation and diversified into medical devices in 1967. BPL Med’s products include Electrocardiographs, Patient Monitors, Defibrillators, Central Nursing Stations, Stress Test Systems, Oxygenerators, Ultrasound Scanners, Colposcopes, Foetal Monitors, Foetal Dopplers and X-Rays.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 23 2013 | 4:24 PM IST

Explore News